Biomarq: A novel approach to automated HER2-analysis of circulating tumor cells (CTCs).

Aurelia Pestka,Thomas W. P. Friedl,Leonie Majunke,Bernadette Jaeger,Ulrich Andergassen,Julia Neugebauer,Julia Kathrin Jueckstock,Jan Keij,Klaus Friese,Tanja Fehm,Volkmar Mueller,Wolfgang Janni,Brigitte Rack

Biomarq: A novel approach to automated HER2-analysis of circulating tumor cells (CTCs).

2017

Aurelia Pestka
Thomas W. P. Friedl
Leonie Majunke
Bernadette Jaeger
Ulrich Andergassen
Julia Neugebauer
Julia Kathrin Jueckstock
Jan Keij
Klaus Friese
Tanja Fehm
Volkmar Mueller
Wolfgang Janni
Brigitte Rack

638 Background: Targeted treatment approaches directed against CTCs might improve the outcome of metastatic breast cancer patients. Accurate and reproducible assessment of the CTC phenotype is a re...

Keywords:

Phenotype
Circulating tumor cell
Pathology
Cancer research
Metastatic breast cancer
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations